Capital Asset Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9
| Closed | -$1K | – | 424 |
|
|
2022
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 446 |
|
|
2022
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 560 |
|
|
2022
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 555 |
|
|
2021
Q4 | $1K | Sell |
9
-918
| -99% | -$102K | ﹤0.01% | 587 |
|
|
2021
Q3 | $57K | Hold |
927
| – | – | 0.01% | 501 |
|
|
2021
Q2 | $57K | Sell |
927
-210
| -18% | -$12.9K | 0.01% | 525 |
|
|
2021
Q1 | $67K | Hold |
1,137
| – | – | 0.01% | 495 |
|
|
2020
Q4 | $68K | Buy |
1,137
+36
| +3% | +$2.15K | 0.01% | 545 |
|
|
2020
Q3 | $60K | Hold |
1,101
| – | – | 0.01% | 368 |
|
|
2020
Q2 | $59K | Buy |
1,101
+501
| +84% | +$26.8K | 0.01% | 395 |
|
|
2020
Q1 | $30K | Buy |
600
+591
| +6,567% | +$29.6K | 0.01% | 382 |
|
|
2019
Q4 | $0 | Buy |
+9
| New | – | ﹤0.01% | 596 |
|